Chromatin proteins and modifications as drug targets
K Helin, D Dhanak - Nature, 2013 - nature.com
A plethora of groundbreaking studies have demonstrated the importance of chromatin-
associated proteins and post-translational modifications of histones, proteins and DNA (so …
associated proteins and post-translational modifications of histones, proteins and DNA (so …
Targeting transcription factors: promising new strategies for cancer therapy
JE Yeh, PA Toniolo, DA Frank - Current opinion in oncology, 2013 - journals.lww.com
Transcription factors are an important target for cancer therapy, both through direct
anticancer effects and immunomodulatory actions. Newly developed delivery systems that …
anticancer effects and immunomodulatory actions. Newly developed delivery systems that …
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
S Picaud, C Wells, I Felletar… - Proceedings of the …, 2013 - National Acad Sciences
Bromodomains have emerged as attractive candidates for the development of inhibitors
targeting gene transcription. Inhibitors of the bromo and extraterminal (BET) family recently …
targeting gene transcription. Inhibitors of the bromo and extraterminal (BET) family recently …
BET bromodomains mediate transcriptional pause release in heart failure
Heart failure (HF) is driven by the interplay between regulatory transcription factors and
dynamic alterations in chromatin structure. Pathologic gene transactivation in HF is …
dynamic alterations in chromatin structure. Pathologic gene transactivation in HF is …
Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening
Bromodomains (BRDs) are epigenetic readers that recognize acetylated-lysine (KAc) on
proteins and are implicated in a number of diseases. We describe a virtual screening …
proteins and are implicated in a number of diseases. We describe a virtual screening …
S6K2: the neglected S6 kinase family member
OE Pardo, MJ Seckl - Frontiers in oncology, 2013 - frontiersin.org
S6 kinase 2 (S6K2) is a member of the AGC kinases super-family. Its closest homolog,
S6K1, has been extensively studied along the years. However, due to the belief in the …
S6K1, has been extensively studied along the years. However, due to the belief in the …
Small-molecule modulators for epigenetics targets.
S Knapp, H Weinmann - ChemMedChem, 2013 - europepmc.org
A capital conference: Influencing epigenetic mechanisms may be highly relevant for future
therapies of various diseases such as cancer, inflammation, and metabolic disorders …
therapies of various diseases such as cancer, inflammation, and metabolic disorders …